Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60 [Phase 1]

View source ↗

Summary

Phase I clinical study to evaluate the safety of the PCV26 pneumococcal vaccine in adults aged 60 and older; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Diseases

Drugs mentioned

• PCV26

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Pneumococcal Diseases | Phase 1 | Status: NOT_YET_RECRUITING